FDB-related hypercholesterolemia is characterized by elevated LDL cholesterol levels engendered by the reduced binding of LDL to LDL receptors and decreased clearance of apoB-containing particles by hepatocytes owing to decreased affinity between mutated APOB-100 and LDL receptors [10]. This evidence concerns the gene APOB and Hypercholesterolemia.